Feasibility and Tolerability of Anlotinib Plus PD-1 Blockades for Patients with Treatment-Refractory Metastatic Colorectal Cancer: A Retrospective Exploratory Study

Feasibility and Tolerability of Anlotinib Plus PD-1 Blockades for Patients with Treatment-Refractory Metastatic Colorectal Cancer: A Retrospective Exploratory Study

Hua Bai, Wen-Hui Wang, Fan-Fan Zhou, Dan Yang, Rui-Jun Li Department of Oncology, People’s Hospital of Zhengzhou, Zhengzhou, People’s Republic of ChinaCorrespondence: Rui-Jun Li, Department of Oncology, People’s Hospital of Zhengzhou, No. 33, Huanghe Road, Jin-Shui District, Zhengzhou, 450053, Peopl...

Full description

Bibliographic Details
Main Authors: Bai H, Wang WH, Zhou FF, Yang D, Li RJ
Format: Article
Language:English
Published: Dove Medical Press 2024-02-01
Series:Cancer Management and Research
Subjects:
: colorectal cancer
anlotinib
pd-1 blockades
efficacy
safety
Online Access:https://www.dovepress.com/feasibility-and-tolerability-of-anlotinib-plus-pd-1-blockades-for-pati-peer-reviewed-fulltext-article-CMAR

Internet

https://www.dovepress.com/feasibility-and-tolerability-of-anlotinib-plus-pd-1-blockades-for-pati-peer-reviewed-fulltext-article-CMAR

Similar Items